Calithera Biosciences (NASDAQ:CALA) reported quarterly losses of $(2.01) per share which missed the analyst consensus estimate of $(1.93) by 4.15 percent. This is a 33 percent increase over losses of $(3.00) per share from the same period last year.
Related Posts
Nvidia CEO Jensen Huang Says AI Will Be ‘Bigger Than The Internet, By Far’
Nvidia CEO Jensen Huang asserted that artificial intelligence is poised to be the most significant technological shift in history.
Spire Global Won $9.4M Contract by National Oceanographic and Oceanic Administration (NOAA) for Satellite Weather Data
Spire Global, Inc. (NYSE:SPIR) ("Spire" or "the Company"), a global provider of space-based data, analytics and space services, has been awarded $9.4 million by the National
Ocuphire Pharma Q3 EPS $(0.22) Up From $(0.25) YoY
Ocuphire Pharma (NASDAQ:OCUP) reported quarterly losses of $(0.22) per share. This is a 12 percent increase over losses of $(0.25) per share from the same period last year.